PT1093366E - Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster - Google Patents

Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster

Info

Publication number
PT1093366E
PT1093366E PT99930482T PT99930482T PT1093366E PT 1093366 E PT1093366 E PT 1093366E PT 99930482 T PT99930482 T PT 99930482T PT 99930482 T PT99930482 T PT 99930482T PT 1093366 E PT1093366 E PT 1093366E
Authority
PT
Portugal
Prior art keywords
agent
antibiral
treatment
pharmaceutical compositions
compositions containing
Prior art date
Application number
PT99930482T
Other languages
English (en)
Inventor
Magnus Leslie
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT1093366E publication Critical patent/PT1093366E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT99930482T 1998-07-09 1999-06-18 Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster PT1093366E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9217198P 1998-07-09 1998-07-09

Publications (1)

Publication Number Publication Date
PT1093366E true PT1093366E (pt) 2005-02-28

Family

ID=22231986

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99930482T PT1093366E (pt) 1998-07-09 1999-06-18 Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster

Country Status (17)

Country Link
EP (1) EP1093366B1 (pt)
JP (1) JP2002520300A (pt)
KR (1) KR20010071776A (pt)
AT (1) ATE279188T1 (pt)
AU (1) AU765246B2 (pt)
CA (1) CA2332929C (pt)
DE (1) DE69921137T2 (pt)
DK (1) DK1093366T3 (pt)
ES (1) ES2230863T3 (pt)
ID (1) ID27395A (pt)
NO (1) NO20010116D0 (pt)
NZ (2) NZ508489A (pt)
PL (1) PL345337A1 (pt)
PT (1) PT1093366E (pt)
SI (1) SI1093366T1 (pt)
WO (1) WO2000002592A1 (pt)
ZA (1) ZA200007169B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541215A (ja) 1999-04-09 2002-12-03 ユーロ−セルティック エス. ア. ナトリウムチャネル遮断薬組成物およびその使用
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
DE60209152T2 (de) 2001-09-03 2006-08-03 Newron Pharmaceuticals S.P.A. Pharmazeutische zusammensetzung, umfassend gabapentin oder ein analogon davon und ein alpha-aminoamid
RS54522B1 (en) 2005-12-22 2016-06-30 Newron Pharmaceuticals S.P.A. 2-Phenylethylamino Derivatives as Modulators of Calcium and (or Sodium) Channels
MX2007006093A (es) * 2007-05-21 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral.
KR20160095358A (ko) 2015-02-03 2016-08-11 고려대학교 산학협력단 우고닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 헤르페스 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9321394D0 (en) * 1993-10-16 1993-12-08 Smihtkline Beecham P L C Pharmaceuticals
AU731279B2 (en) * 1996-03-14 2001-03-29 Warner-Lambert Company Novel bridged cyclic amino acids as pharmaceutical agents
US6001876A (en) * 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain

Also Published As

Publication number Publication date
DE69921137T2 (de) 2006-02-02
ZA200007169B (en) 2002-03-04
ID27395A (id) 2001-04-05
EP1093366A1 (en) 2001-04-25
PL345337A1 (en) 2001-12-17
CA2332929A1 (en) 2000-01-20
ATE279188T1 (de) 2004-10-15
NZ525623A (en) 2005-08-26
AU4701699A (en) 2000-02-01
CA2332929C (en) 2005-05-31
AU765246B2 (en) 2003-09-11
DK1093366T3 (da) 2004-12-06
NO20010116L (no) 2001-01-08
JP2002520300A (ja) 2002-07-09
NO20010116D0 (no) 2001-01-08
WO2000002592A1 (en) 2000-01-20
NZ508489A (en) 2004-06-25
SI1093366T1 (en) 2005-02-28
EP1093366B1 (en) 2004-10-13
KR20010071776A (ko) 2001-07-31
ES2230863T3 (es) 2005-05-01
DE69921137D1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
BR9809115A (pt) Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt
IS2749B (is) Ný tegund af lyfjablöndu
BR9813474A (pt) Processo para intensificar uma absorção pelo animal de pelo menos um composto lipofìlico, e, composição
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
ES2188656T3 (es) Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral.
IS4576A (is) Lyfjasamsetning sem inniheldur prótónudælulata
BR9800932A (pt) Enriquecimento de alimentos.
DK0696456T3 (da) Kombination af nekrosefremkaldende stoffer med stoffer, som aktiveres af nekroser, til selektiv behandling af tumorer og betændelsessygdomme
WO2000002546A3 (en) Use of caba-analogues for treating insomnia
PT1093366E (pt) Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster
DK0994704T3 (da) Anvendelse af GABA-analoger såsom gabapentin i fremstillingen af et medikament til behandling af inflammatoriske sygdomme
BR9814711A (pt) Composições e processos para aumentar a concentração e/ou motilidade de espermatozóides em seres humanos
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
BR9811126A (pt) Processo de estabilizar os ésteres do ácido (met) acrìlico
DK159094C (da) Anvendelse af vandige natrium- eller kaliummethioninatoploesninger til supplering af blandingsfoder med methionin
BR9916156A (pt) Método e composição para a manutenção e restituição de integridade do intestino
BR9911950A (pt) Composição farmacêutica contendo análogos gaba e um agente antiviral para tratamento de herpes zoster
PT89303A (pt) Processo para a preparacao de tienotriciclos e de composicoes farmaceuticas que os contem
ES2183158T3 (es) Poli(acidos organicos) y sus analogos para aumentar la eficacia herbicida.
KR890000399A (ko) (e)-2-(p-플루오로펜에틸)-3-플루오로알릴아민
BR9911943A (pt) Composições compreendendo análogos gaba e um descongestionante para aliviar dor de cabeça de sino
PT89350A (pt) Processo para a preparacao de uma combinacao sinergistica de inibidores de descarboxilase e de l-dopa e de composicoes farmaceuticas que a contem
PT561141E (pt) Solucao altamente concentrada em aminoacidos
CO4600662A1 (es) Modificadores cristalinos para grasas diacetinicas